Dylan Scott: A New Chapter and a Way to Give Back to the Bleeding Disorder Community
Dylan Scott, Territory Manager at InfuCare Rx, shared a post on LinkedIn:
“A New Chapter and A Way to Give Back to the Bleeding Disorder Community.
I’m excited to share that I’m now working with InfuCare Rx!
One of the things I’m most passionate about is helping people in the bleeding disorder community feel more informed and supported when it comes to specialty pharmacy, hemophilia, and navigating care.
As someone who is also a member of the community, I know how many questions can come up — whether you’re a parent or caregiver, a young person getting ready to manage things on your own, or someone who simply wants to better understand hemophilia.
So, in my spare time, I’ll be creating short TikTok videos covering things like:
- Hemophilia A and B basics
- Understanding factor and other hemophilia treatments
- How specialty pharmacies fit into your care
- Questions you may want to ask your specialty pharmacy
- Tips and information for parents and caregivers
- Things to know as you transition to managing your care independently
- Common questions I hear from the community
- And topics YOU want to know more about
My goal isn’t to tell anyone which treatment, doctor, or pharmacy is right for them. It’s to provide information, share experiences, and help people know what questions to ask.
If you have questions about specialty pharmacy or hemophilia that you’d like me to cover, drop them in the comments or send me a message! I’d love to turn your questions into future videos.
Important disclaimer: These videos and posts are created by me in my personal time as a member of the bleeding disorder community. They are for general educational and informational purposes only and do not represent, speak on behalf of, or necessarily reflect the views of InfuCare Rx or its affiliates. Nothing I share is intended to replace advice from your healthcare provider.
Let’s learn, ask questions, and support each other.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 16:28Jon Douglas: Imperial College London Review Maps Key Pathways in Autoimmune Thrombosis
-
Sep 5, 2026, 16:21Kelly Anderson: Bilateral Foot Pain and Purple Toes – Spotting Vascular Complications in Polycythemia Vera
-
Sep 5, 2026, 16:16Hazem Abosheaishaa: Beta-Blocker Selection Matters – Multi-Institutional Cohort Insights on PVT and Survival in Cirrhosis
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?